Guardant Health GH
NASDAQ GH
$182.99 +8.09 (+4.63%)
As of: Sep 17, 2026 · 3:59 PM EDT

Guardant Health (GH) Cash from Operations Growth (3y) (2020 - 2026)

Analysis

Guardant Health (GH) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 39.21%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 10.37%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 8.23%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 14.98%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 31.29%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 35.23%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 136.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.98%
Mar 31, 2026 4.12%
Dec 31, 2025 33.76%
Sep 30, 2025 23.19%
Jun 30, 2025 18.64%
Mar 31, 2025 -29.87%
Dec 31, 2024 5.72%
Sep 30, 2024 1.33%
Jun 30, 2024 -14.52%
Mar 31, 2024 -22.96%
Dec 31, 2023 -9.95%
Sep 30, 2023 -112.94%
Jun 30, 2023 -59.05%
Mar 31, 2023 -77.63%
Dec 31, 2022 -44.08%
Sep 30, 2022 -291.54%
Jun 30, 2022 -100.75%
Mar 31, 2022 -88.06%
Dec 31, 2021 -42.62%
Sep 30, 2021 -34.08%